|Year : 2016 | Volume
| Issue : 3 | Page : 319-320
Glioblastoma with signet ring cell morphology: A diagnostic challenge
Naveen Krishnamoorthy1, Vidya Veldore2, PS Sridhar3, MJ Govindrajan4, Shilpa Prabhudesai1, Digantha Hazarika1, BS Ajaikumar3
1 Department of Histopathology, Triesta Reference Laboratory, HCG Bangalore Institute of Oncology, Bengaluru, Karnataka, India
2 Department of Research and Development, Triesta Reference Laboratory, HCG Bangalore Institute of Oncology, Bengaluru, Karnataka, India
3 Department of Radiotherapy, HCG Bangalore Institute of Oncology, Sampangiram Nagar, Bengaluru, Karnataka, India
4 Department of Radiodiagnosis, HCG Bangalore Institute of Oncology, Sampangiram Nagar, Bengaluru, Karnataka, India
|Date of Web Publication||5-Apr-2016|
Dr. Naveen Krishnamoorthy
Department of Pathology, Triesta Reference Laboratory, HCG Bangalore Institute of Oncology, # 8, 2nd Floor, HCG Tower, P. Kalinga Rao Road, Sampangiram Nagar, Bengaluru, Karnataka
Source of Support: None, Conflict of Interest: None
Glioblastoma (WHO Grade IV), the most frequent malignant brain tumor, can have varied morphologic variations like epithelial/glandular structures, granular cells, and lipidized cells. Glioblastoma with signet ring cell morphology is very unusual and can mimic a metastatic carcinoma. These rare tumors may be just a morphological variant or may signify a different carcinogenic pathway.
Keywords: Glioblastoma, signet ring morphology, mimic-metastatic carcinoma
|How to cite this article:|
Krishnamoorthy N, Veldore V, Sridhar P S, Govindrajan M J, Prabhudesai S, Hazarika D, Ajaikumar B S. Glioblastoma with signet ring cell morphology: A diagnostic challenge. Asian J Neurosurg 2016;11:319-20
|How to cite this URL:|
Krishnamoorthy N, Veldore V, Sridhar P S, Govindrajan M J, Prabhudesai S, Hazarika D, Ajaikumar B S. Glioblastoma with signet ring cell morphology: A diagnostic challenge. Asian J Neurosurg [serial online] 2016 [cited 2020 May 30];11:319-20. Available from: http://www.asianjns.org/text.asp?2016/11/3/319/149998
| Introduction|| |
The prototype glioblastoma (WHO Grade IV), the most frequent and malignant primary brain tumor, generally does not pose a diagnostic difficulty to the pathologist. Occasionally variations in the tumor morphology like epithelial/glandular structures, granular cells, lipidized cells, and very rarely, signet ring cell morphology do challenge the pathologist. Herein, we report a rare case of glioblastoma with signet ring cell morphology and underlie its importance so as to prevent an erroneous diagnosis of metastatic carcinoma.
| Case Report|| |
A 29 year-old doctor came with complaints of persistent headache and occasional vomiting since 2 months. He had brief episodes of altered sensorium during this period. He was evaluated with a computed tomography (CT) scan [Figure 1] which showed a large 7 × 5 × 6 cm intraaxial space occupying lesion (SOL) in the right parietotemporal region with solid and cystic components and significant perilesional edema and midline shift. On magnetic resonance imaging (MRI) scan, the lesion was hyperintense on T2 with central area of T1 hypointensity. The lesion demonstrated diffusion restriction with apparent diffusion coefficient (ADC), showed intense enhancement on contrast administration, and MR spectroscopy revealed choline peak. Overall, radiological impression was of a high-grade glioma. Patient underwent craniotomy and excision of the lesion.
|Figure 1: (a) Pet CT scan and (b) T1-MRI showing right parieto-temporal lesion with solid and cystic components with significant perillesional edema and midline shift|
Click here to view
Histology [Figure 2] revealed a high-grade neoplasm composed of sheets and single scattered cells with majority of them having cytoplasmic inclusions pushing the nucleus to the periphery, thus displaying signet ring cell morphology. At places, the cells had a gemistocytic look, but processes from the cells or a fibrillary background were not conspicuous. Cells displayed moderate pleomorphism. Focal necrosis was noted. There was no microvascular proliferation. No other pattern or native brain tissue was identified. Stain for mucin was negative.
|Figure 2: (a) Sheets of large cells exhibiting pleomorphism (b) individual cells exhibit signet ring cell morphology (H and E, ×200) tumor cells are positive for gfap (c), vimentin (d), negative for cytokeratin (e) and focaly positive for p53 (f)|
Click here to view
On immunohistochemistry, the cells were positive for glial fibrillary acidic protein (GFAP), vimentin, and S-100 protein. They showed p53 positivity, suggesting astrocytic lineage. They were negative for cytokeratin, epithelial membrane antigen (EMA), synaptophysin, and HMB-45. Ki-67 proliferating index was around 10%. This confirmed a diagnosis of a glioblastoma with unusual signet ring cell morphology.
O6- methylguanine-DNA methyltransferase (MGMT) promoter methylation was demonstrated in this case by polymerase chain reaction (PCR).
There were no deletions of 1p19q chromosome on florescence in situ hybridization (FISH).
| Discussion|| |
Glioblastoma (WHO Grade IV) is the most malignant primary brain neoplasm and is of astrocytic lineage. The prototype histology comprises poorly differentiated pleomorphic astrocytes with nuclear atypia and mitotic activity. Microvascular proliferation and/or necrosis are necessary for its diagnosis.
The presence of signet ring cells is very unusual in glioblastomas with only one previous case reported in literature till date. However, signet ring cells have earlier been described in primary CNS tumors like oligodendroglioma, ependymoma, primary CNS lymphoma, oligoastrocytoma, and astroblastoma.
This signet ring cell morphology can be confused with metastatic adenocarcinoma from the gastrointestinal tract. It is in these situations that immunohistochemistry is so useful to exactly delineate the cell of origin. Positivity for GFAP and negativity for cytokeratin confirmed glial origin of the signet ring cells. Furthermore, absence of 1p19q deletion and p53 positivity supported an astrocytic lineage of the tumor.
Rosenblum et al. reported four cases of lipid-rich epithelioid glioblastoma, but those had cells with centrally placed nuclei and multiple cytoplasmic lipid droplets which expressed cytokeratin, unlike our case which had typical signet ring cell morphology and was cytokeratin negative.
Martin et al. described a glioblastoma very similar to our case, which had sheets of signet ring cells with nuclear atypia, mitoses, extensive necrosis, and vascular proliferation. On immunohistochemistry, the cells were positive for GFAP and S100, and negative to cytokeratin. Electron microscopy revealed stacks of intermediate filaments, and FISH for 1p19q did not show any deletions.
Despite progress in surgery, radiotherapy, and chemotherapy of brain tumors, the overall survival of patients with glioblastoma remains extremely poor. Previous reports have shown a relative favorable prognosis for signet ring cell tumors of the CNS., Our patient expired within 5 months of symptoms and 3 months of diagnosis as was the case reported by Martin et al.
Due to the very few cases in literature, it remains to be seen whether signet ring cell glioblastoma is just a morphological variant or signifies a different carcinogenic pathway.
| References|| |
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors. WHO Classification of Tumors of the Central Nervous System. Lyon: IARC; 2007.
Martin SE, Bonnin JM, Hall DC, Hattab EM. Glioblastoma with signet – ring morphology: A case report and review of the literature. Hum Pathol 2010;41:443-6.
Mikami Y, Shirabe T, Hata S, Watanabe A. Oligodendroglioma with signet – ring cell morphology: A case report with an immunohistochemical and ultrastructural study. Pathol Int 1998;48:144-50.
Vajtai I, Musci Z, Varga Z, Bodi I. Signet-ring cell ependymoma: Case report with implications for pathogenesis and differential diagnoses. Pathol Res Pract 1999;195:853-8.
Kim H, Dorfman RF, Rappaport H. Signet ring cell lymphoma. A rare morphologic and functional expression of nodular (follicular) lymphoma. Am J Surg Pathol 1978;2:119-32.
Ramos D, Cerda-Nicolas M, Lopez-Gines C, Roldán P, Molla J, Pérez-Bacete M, et al
. Oligoastrocytoma with signet ring cell differentiation. A morphological, ultrstructural and immunohistochemical study. Neurocirugia (Astur) 2003;14:46-51.
Sugita Y, Terasaki M, Shigemori M, Morimatsu M, Honda E, Oshima Y. Astroblastoma with unusual signet-ring like cell components: A case report and literature review. Neuropathology 2002;22:200-5.
Rosenblum MK, Erlandson RA, Budzilovich GN. The lipid – rich epithelioid glioblastoma. Am J Surg Pathol 1991;15:925-34.
Pappas CT, Johnson PC, Sonntag VK. Signet-ring cell lymphoma of the central nervous system. Case report. J Neurosurg 1998;69:789-92.
Kros JM, van den Brink WA, van Loon-van Luy tJJ, Stefanko SZ. Signet – ring cell oligodenroglioma-report of two cases and discussion of the differential diagnosis. Acta Neuropathol 1997;93:638-43.
[Figure 1], [Figure 2]